These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 40511

  • 1. [The "the therapeutic window" of neuroleptic levels in the erythrocytes of schizophrenics (proceedings)].
    Yesavage JA.
    Ann Med Psychol (Paris); 1979; 137(3-4):251. PubMed ID: 40511
    [No Abstract] [Full Text] [Related]

  • 2. Relapse rate and low serum neuroleptic levels in schizophrenics treated with fluphenazine: another view.
    Boza RA, Milanes F, Starkey T, Slater V, Dominguez F.
    J Clin Psychiatry; 1988 Jun; 49(6):245. PubMed ID: 2897960
    [No Abstract] [Full Text] [Related]

  • 3. Neuroleptic-refractory patients and their drug plasma levels.
    Berrios GE.
    Encephale; 1982 Jun; 8(4):465-85. PubMed ID: 6129961
    [Abstract] [Full Text] [Related]

  • 4. Neuroleptic levels by radioreceptor assay and clinical response during treatment of acute exacerbation of schizophrenia--some preliminary findings.
    Greenberg JS, Brown WA, Laughren TP, Krantz J.
    Psychopharmacol Bull; 1983 Jun; 19(1):74-6. PubMed ID: 6131470
    [No Abstract] [Full Text] [Related]

  • 5. Neuroleptic concentrations in schizophrenic patients: measurements by radioreceptor assay and gas chromatography.
    Javaid JI, Davis JM, Dysken MW, Janicak P, Casper R.
    Psychopharmacol Bull; 1983 Jun; 19(1):72-4. PubMed ID: 6131469
    [No Abstract] [Full Text] [Related]

  • 6. The relationship between plasma and red blood cell neuroleptic levels, oral dosage, and clinical parameters in a chronic schizophrenic population.
    Dunlop SR, Shea PA, Hendrie HC.
    Biol Psychiatry; 1982 Aug; 17(8):929-36. PubMed ID: 6126231
    [Abstract] [Full Text] [Related]

  • 7. Prediction of treatment response in schizophrenia: clinical use of neuroleptic blood levels.
    Tang SW.
    Can J Psychiatry; 1985 Jun; 30(4):249-50. PubMed ID: 2861888
    [Abstract] [Full Text] [Related]

  • 8. Neuroleptic blood levels in outpatient maintenance therapy of schizophrenia.
    Sajadi C, Smith RC, Shvartsburd A, Morton V, Mirabi M, Gordon J.
    Psychopharmacol Bull; 1984 Jun; 20(1):110-3. PubMed ID: 6144129
    [No Abstract] [Full Text] [Related]

  • 9. Serum neuroleptic levels in the maintenance treatment of schizophrenia.
    Brown WA, Laughren T.
    Psychopharmacol Bull; 1983 Jun; 19(1):76-8. PubMed ID: 6131471
    [No Abstract] [Full Text] [Related]

  • 10. Lack of relationship of neuroleptic dose and blood serum levels to neuropsychological performance on the LNNB in chronic schizophrenia.
    Puente AE, Tune L.
    Int J Neurosci; 1996 Oct; 87(1-2):107-10. PubMed ID: 8913825
    [Abstract] [Full Text] [Related]

  • 11. Serotonin uptake and efflux in blood platelets from untreated and neuroleptic-treated schizophrenics.
    Lingjaerde O.
    Biol Psychiatry; 1983 Dec; 18(12):1345-56. PubMed ID: 6140960
    [Abstract] [Full Text] [Related]

  • 12. Plasma homovanillic acid levels and therapeutic outcome in schizophrenics: comparisons of neuroleptic-naive first-episode patients and patients with disease exacerbation due to neuroleptic discontinuance.
    Akiyama K, Tsuchida K, Kanzaki A, Ujike H, Hamamura T, Kondo K, Mutoh S, Miyanagi K, Kuroda S, Otsuki S.
    Biol Psychiatry; 1995 Nov 15; 38(10):639-48. PubMed ID: 8555375
    [Abstract] [Full Text] [Related]

  • 13. Serum neuroleptic levels, prolactin levels, and relapse: a two-year study of schizophrenic outpatients.
    Faraone SV, Brown WA, Laughren TP.
    J Clin Psychiatry; 1987 Apr 15; 48(4):151-4. PubMed ID: 2881923
    [Abstract] [Full Text] [Related]

  • 14. [Dynamics of the serum pipothiazine level in patients with schizophrenia during long-term treatment with this neuroleptic agent].
    Lipska B, Szukalski B, Nurowska K, Welbel L.
    Psychiatr Pol; 1987 Apr 15; 21(1):14-9. PubMed ID: 2887001
    [No Abstract] [Full Text] [Related]

  • 15. [Serum prolactin levels in chronic schizophrenics].
    Ravalli S, Barone R, Molinaro G, Leone NB.
    Minerva Psichiatr; 1987 Apr 15; 28(1):31-4. PubMed ID: 2888003
    [No Abstract] [Full Text] [Related]

  • 16. Radioreceptor assay of neuroleptics in refractory chronic schizophrenic patients.
    Lindenmayer JP, Smith D, Katz I.
    J Clin Psychiatry; 1984 Mar 15; 45(3):117-9. PubMed ID: 6142035
    [Abstract] [Full Text] [Related]

  • 17. Increase of risperidone concentration under chlorprothixene comedication--a case report.
    Bader W, Greiner C, Haen E.
    Pharmacopsychiatry; 2008 May 15; 41(3):116-7. PubMed ID: 18484554
    [No Abstract] [Full Text] [Related]

  • 18. Abnormalities in 5-HT2A receptor mRNA expression in frontal cortex of chronic elderly schizophrenics with varying histories of neuroleptic treatment.
    Hernandez I, Sokolov BP.
    J Neurosci Res; 2000 Jan 15; 59(2):218-25. PubMed ID: 10650880
    [Abstract] [Full Text] [Related]

  • 19. Prolactin and neuroleptic drugs.
    Green AI, Brown WA.
    Endocrinol Metab Clin North Am; 1988 Mar 15; 17(1):213-23. PubMed ID: 2897910
    [Abstract] [Full Text] [Related]

  • 20. [Blood levels of beta-endorphins and the changes caused by neuroleptics in acute and chronic schizophrenics].
    Barcia D, Martínez A, López L, Ruiz ME, Galiana M, Muñoz R, Huertas F.
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1984 Mar 15; 12(1):3-10. PubMed ID: 6144248
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.